$50K EBITDA Cancer Research Bioinformatics Software Company in Ann Arbor 1433

Research conducted at Wayne State University and the Karmanos Cancer Institute illuminated the need for bioinformatics software as a missing component for effective cancer research. The Seller developed next-generation algorithms and tools that significantly improved researchers’ ability to interpret experimental data. These were initially offered for free through a university laboratory website, where they gained rapid adoption. Recognizing the broader demand and the need for sustainable growth, the company transitioned into a commercial enterprise with the support of grants, including a $150,000 SBIR prototype. Through the years, the Company developed multiple trademarks and patents. Today, the software bridges the critical gap between the massive data generated by modern laboratory equipment and actionable biological insights with specialized cloud-based software solutions to create high-throughput biological data analysis. The company’s software transforms terabytes of raw data into meaningful knowledge for life sciences and medical research. NDA is required to secure the comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information Facilities: Company headquarters are in a commercial office building owned by the Seller. The Company rents the 2,000-square-foot, seven-office space for $3,500 per month. Competition: The industry landscape is quite competitive, but the Company is growing and has a well-established reputation that a Buyer can capitalize on with marketing. Growth & Expansion: To grow the company, maximize opportunities in its field, and become more profitable, the Seller suggests that the buyer launch a single-cell platform and integrate AI capabilities. Financing: TBD if the structure and terms are acceptable. Support & Training: The Seller is interested in maintaining a technical role within the company post-sale, potentially as a CTO, technical consultant, or board member, to continue contributing his expertise in developing advanced products, including AI-driven technologies. Reason for Selling: The Seller believes that he is best in the role of data scientist, not the CSO or CMO.